Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

and Roche Holding (RHHBY – Research Report). Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment ...

Gilead and Roche are continuing to lay off employees in California, with each company revealing a recent round of cuts through the state’s Worker Adjustment and Retraining Notification (WARN ...

Subscribe Login Register Log out My Profile Subscriber Services Search EBLADE ENTER-TO-WIN BLADE REWARDS BLADE VAULT / REPRINTS OBITUARIES JOBS CLASSIFIEDS BLADE HOMES HOMES WEEKLY ADS EVENTS ...

NEW YORK – With new agreements with Laboratory Corporation of America and Quest Diagnostics announced last week, Roche is ramping up commercialization of its sample self-collection devices for human ...

The Celtics are in the midst of another impressive season as they look to repeat as NBA champions. But once the season ends, they’ll have to make a tough decision to either keep their core ...

New Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss pharmaceutical giant F Hoffmann-La Roche AG, which sought to ...

The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La Roche AG against Indian drugmaker Natco Pharma Limited alleging that the ...